Finally, with the regulated balance between CD8+ T cells and tumor burden, the number of intratumoral CD8+ T cells was increased and IFN-γ secretion was increased by anti-PD-1, thereby enhancing the efficacy of anti-PD-1 therapy. Here, PDCD1 is linked to neoplasm.